GeneThera Market Capitalization vs. Book Value Per Share
| GTHR Stock | USD 0.0001 0.00 0.00% |
For GeneThera profitability analysis, we use financial ratios and fundamental drivers that measure the ability of GeneThera to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well GeneThera utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between GeneThera's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of GeneThera over time as well as its relative position and ranking within its peers.
GeneThera |
GeneThera Book Value Per Share vs. Market Capitalization Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining GeneThera's current stock value. Our valuation model uses many indicators to compare GeneThera value to that of its competitors to determine the firm's financial worth. GeneThera is one of the top stocks in market capitalization category among its peers. It also is one of the top stocks in book value per share category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GeneThera's earnings, one of the primary drivers of an investment's value.GeneThera Market Capitalization vs. Competition
GeneThera is one of the top stocks in market capitalization category among its peers. Market capitalization of Biotechnology industry is currently estimated at about 12.94 Billion. GeneThera adds roughly 533,532 in market capitalization claiming only tiny portion of stocks in Biotechnology industry.
GeneThera Book Value Per Share vs. Market Capitalization
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
GeneThera |
| = | 533.53 K |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
GeneThera |
| = | (0.24) X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
GeneThera Book Value Per Share Comparison
GeneThera is currently under evaluation in book value per share category among its peers.
GeneThera Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in GeneThera, profitability is also one of the essential criteria for including it into their portfolios because, without profit, GeneThera will eventually generate negative long term returns. The profitability progress is the general direction of GeneThera's change in net profit over the period of time. It can combine multiple indicators of GeneThera, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. The companys Molecular RoboticAI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. Genethera operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
GeneThera Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on GeneThera. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of GeneThera position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the GeneThera's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in GeneThera without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Use Investing Themes to Complement your GeneThera position
In addition to having GeneThera in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Funds Thematic Idea Now
Money Funds
Funds or Etfs that invest most if their asset in companies from financial sector such as commercial banks, insurance companies, investment funds, and real estate. The Money Funds theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for GeneThera Pink Sheet Analysis
When running GeneThera's price analysis, check to measure GeneThera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneThera is operating at the current time. Most of GeneThera's value examination focuses on studying past and present price action to predict the probability of GeneThera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneThera's price. Additionally, you may evaluate how the addition of GeneThera to your portfolios can decrease your overall portfolio volatility.